Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon- beta Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells. e70626
Interferon- beta is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structure...
Gespeichert in:
Veröffentlicht in: | PloS one 2013-08, Vol.8 (8) |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!